|
LRP12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.484820E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.065700E-02 |
| Normal-vs-Stage2 |
8.158000E-01 |
| Normal-vs-Stage3 |
4.993800E-01 |
| Normal-vs-Stage4 |
7.310600E-01 |
| Stage1-vs-Stage2 |
3.388800E-01 |
| Stage1-vs-Stage3 |
3.352000E-01 |
| Stage1-vs-Stage4 |
1.861560E-01 |
| Stage2-vs-Stage3 |
8.042000E-01 |
| Stage2-vs-Stage4 |
9.926000E-01 |
| Stage3-vs-Stage4 |
7.550600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.681840E-01 |
| Normal-vs-AfricanAmerican |
2.147600E-02 |
| Normal-vs-Asian |
3.612000E-01 |
| Caucasian-vs-AfricanAmerican |
4.576500E-02 |
| Caucasian-vs-Asian |
9.929200E-01 |
| AfricanAmerican-vs-Asian |
8.386000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.408400E-01 |
| Normal-vs-Female |
5.503800E-02 |
| Male-vs-Female |
3.903500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.360200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.279800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.073800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.945000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.116630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.379600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.736000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.357400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.312800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.860200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.355800E-01 |
| Classical-VS-Follicular |
7.89749999952072E-07 |
| Classical-VS-Other |
2.025000E-01 |
| Classical-VS-Normal |
5.183100E-03 |
| Tall-VS-Follicular |
3.252300E-02 |
| Tall-VS-Other |
4.280200E-01 |
| Tall-VS-Normal |
4.219800E-01 |
| Follicular-VS-Other |
7.426600E-01 |
| Follicular-VS-Normal |
5.942200E-02 |
| Other-VS-Normal |
6.047800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.816000E-01 |
| Normal-vs-N1 |
8.126800E-01 |
| N0-vs-N1 |
8.028200E-01 |
|
|
